Brookfield, CT, United States of America

Chris Hugh Senanayake

This inventor holds 77 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 16 EPO patents, primarily in Chiral Ligands (CPC class C07C). Top assignees: Sepracor, Inc., Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 1999-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chris Hugh Senanayake. Retrieved from https://idiyas.com/inventor/chris-hugh-senanayake

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 77 (Patent Applications = 6)

% Patents Active = 83.1

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 16 (Patent Applications = 21)

Average Co-Inventor Count = 4.2

ph-index = 13

Forward Citations = 715(Granted Patents)

Forward Citations (Not Self Cited) = 659(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Danbury, CT (US) (2004)
Shrewsbury, MA (US) (1999 - 2010)
Ridgefield, CT (US) (2010)
Brookfield, CT (US) (2006 - 2020)

Company Filing History:

Boehringer Ingelheim International Gmbh

patents

5 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

Sunovion Pharmaceuticals Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2020

Loading Chart...

Areas of Expertise:

Chiral Ligands

COPD Treatments

Asymmetric Synthesis

Dihydrothienopyrimidines

Cross-Coupling Reactions

Ruthenium Catalysts

Diastereomeric Compounds

Macrocyclic Compounds

Acyclic HCV Protease Inhibitors

Stereoselective Synthesis

Nitrogen-Phosphorus Ligands

Glucocorticoids

77 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10745411 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2020-08-18),

2. 10544177 - Chiral dihydrobenzooxaphosphole ligands and synthesis thereof (2020-01-28),

3. 10221203 - Chiral dihydrobenzooxaphosphole ligands and synthesis thereof (2019-03-05),

4. 10196413 - Chiral dihydrobenzoazaphosphole ligands and synthesis thereof (2019-02-05),

5. 9802954 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2017-10-31),

6. 9150586 - Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma (2015-10-06),

7. 9096626 - Monophosphorus ligands and their use in cross-coupling reactions (2015-08-04),

8. 9079832 - [object Object] (2015-07-14),

9. 9029540 - Ruthenium catalysts and their use for asymmetric reduction of ketones (2015-05-12),

10. 8975447 - Process for asymetric methylallylation in the presence of a 2,2'-substituted 1,1′-BI-2-naphthol catalyst (2015-03-10),

11. 8946418 - Chiral nitrogen-phosphorus ligands and their use for asymmetric hydrogenation of alkenes (2015-02-03),

12. 8916701 - Methods of making diastereomeric organic compounds (2014-12-23),

13. 8816112 - Process for making novel chiral phosphorus ligands (2014-08-26),

14. 8710036 - [object Object] (2014-04-29),

15. 8653282 - Preparation of dihydrothieno [3,2-D] pyrimidines and intermediates used therein (2014-02-18),

Certainly! Here is the article for inventor Chris Hugh Senanayake:

Title: Unveiling the Innovations of Inventor Chris Hugh Senanayake

Introduction:

Chris Hugh Senanayake is a prolific inventor hailing from Brookfield, CT (US), known for his remarkable contributions to the world of patents and inventions. With an impressive portfolio of 77 patents, Senanayake has made significant strides in the fields of pharmaceuticals and organic transformations.

Latest Patents:

Some of his latest patents include:

1. Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma

2. Chiral dihydrobenzooxaphosphole ligands and synthesis thereof

Career Highlights:

Senanayake has had a distinguished career, with notable stints at renowned companies such as Sepracor, Inc. and Boehringer Ingelheim International GmbH. Through his work, he has demonstrated a keen understanding of pharmaceuticals and organic synthesis, paving the way for groundbreaking innovations in the industry.

Collaborations:

Throughout his career, Chris Hugh Senanayake has collaborated with esteemed professionals in the field, including Xudong Wei and Nizar Haddad. Together, they have worked on cutting-edge projects that have pushed the boundaries of what is possible in the world of patents and inventions.

Conclusion:

In conclusion, Chris Hugh Senanayake stands as a beacon of innovation, with a remarkable track record of patent applications that have revolutionized the fields of pharmaceuticals and organic transformations. His dedication to pushing the boundaries of scientific discovery continues to inspire inventors and innovators around the world.

Profile summary based on public USPTO records.